Adalimumab for Nail Psoriasis: Efficacy and Safety from the Open-Label Extension of a Phase-3, Randomized, Placebo-Controlled Trial. SKIN The Journal of Cutaneous Medicine, [S. l.], v. 1, n. 3.1, p. s97, 2017. DOI: 10.25251/skin.1.supp.96. Disponível em: https://skin.dermsquared.com/skin/article/view/75. Acesso em: 25 jun. 2025.